mouse fasii Search Results


94
MedChemExpress anti fasii antibiotic afn 1252
Hlb activity and anti-FASII treatments enhance C18:2 incorporation in S. aureus PLs. TB3 (фNM3 in hlb ) and TB4 (no phage) strains were cultured in BHI medium supplemented with 10% mouse serum, 30 μM 1,3DG, with or without 0.5 <t>μg/ml</t> <t>AFN-1252</t> (anti-FASII), and with or without 50 μM GW4869 (inhibitor of Hlb). Top left: bacterial growth rates in the absence of anti-FASII treatment, performed in glass tubes. Top right: growth kinetics in the presence of AFN-1252, measured in 96-well microtiter plates with OD600 reading every 10 min. Bottom: C18:2 incorporation with or without AFN-1252. C18:2 incorporation was determined in the TB4 and TB3 strains as described in <xref ref-type=Figure 2 B. Data are means ± standard deviations from independent experiments (n = 4). Statistical significance was determined by the Mann-Whitney test for on OD 600 /h and by the Wilcoxon Signed Rank test for incorporated C18:2; ∗, P ≤ 0.05. n.s: not significant. " width="250" height="auto" />
Anti Fasii Antibiotic Afn 1252, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+fasii/AFN-1252/pmc11721228-46-40-45
Average 94 stars, based on 1 article reviews
anti fasii antibiotic afn 1252 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

96
Novus Biologicals mouse fasii
Hlb activity and anti-FASII treatments enhance C18:2 incorporation in S. aureus PLs. TB3 (фNM3 in hlb ) and TB4 (no phage) strains were cultured in BHI medium supplemented with 10% mouse serum, 30 μM 1,3DG, with or without 0.5 <t>μg/ml</t> <t>AFN-1252</t> (anti-FASII), and with or without 50 μM GW4869 (inhibitor of Hlb). Top left: bacterial growth rates in the absence of anti-FASII treatment, performed in glass tubes. Top right: growth kinetics in the presence of AFN-1252, measured in 96-well microtiter plates with OD600 reading every 10 min. Bottom: C18:2 incorporation with or without AFN-1252. C18:2 incorporation was determined in the TB4 and TB3 strains as described in <xref ref-type=Figure 2 B. Data are means ± standard deviations from independent experiments (n = 4). Statistical significance was determined by the Mann-Whitney test for on OD 600 /h and by the Wilcoxon Signed Rank test for incorporated C18:2; ∗, P ≤ 0.05. n.s: not significant. " width="250" height="auto" />
Mouse Fasii, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+fasii/DYKDDDDK+Epitope+Tag+Antibody+(L5)/10__1523_slash_eneuro__0403___21__2021-134-47-53
Average 96 stars, based on 1 article reviews
mouse fasii - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

95
Proteintech fasii mouse monoclonal dshb monoclonal 1d4
Hlb activity and anti-FASII treatments enhance C18:2 incorporation in S. aureus PLs. TB3 (фNM3 in hlb ) and TB4 (no phage) strains were cultured in BHI medium supplemented with 10% mouse serum, 30 μM 1,3DG, with or without 0.5 <t>μg/ml</t> <t>AFN-1252</t> (anti-FASII), and with or without 50 μM GW4869 (inhibitor of Hlb). Top left: bacterial growth rates in the absence of anti-FASII treatment, performed in glass tubes. Top right: growth kinetics in the presence of AFN-1252, measured in 96-well microtiter plates with OD600 reading every 10 min. Bottom: C18:2 incorporation with or without AFN-1252. C18:2 incorporation was determined in the TB4 and TB3 strains as described in <xref ref-type=Figure 2 B. Data are means ± standard deviations from independent experiments (n = 4). Statistical significance was determined by the Mann-Whitney test for on OD 600 /h and by the Wilcoxon Signed Rank test for incorporated C18:2; ∗, P ≤ 0.05. n.s: not significant. " width="250" height="auto" />
Fasii Mouse Monoclonal Dshb Monoclonal 1d4, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+fasii/acetylated+Tubulin(Lys40)+Antibody/pm34977501-253-2-15
Average 95 stars, based on 1 article reviews
fasii mouse monoclonal dshb monoclonal 1d4 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

Image Search Results


Hlb activity and anti-FASII treatments enhance C18:2 incorporation in S. aureus PLs. TB3 (фNM3 in hlb ) and TB4 (no phage) strains were cultured in BHI medium supplemented with 10% mouse serum, 30 μM 1,3DG, with or without 0.5 μg/ml AFN-1252 (anti-FASII), and with or without 50 μM GW4869 (inhibitor of Hlb). Top left: bacterial growth rates in the absence of anti-FASII treatment, performed in glass tubes. Top right: growth kinetics in the presence of AFN-1252, measured in 96-well microtiter plates with OD600 reading every 10 min. Bottom: C18:2 incorporation with or without AFN-1252. C18:2 incorporation was determined in the TB4 and TB3 strains as described in <xref ref-type=Figure 2 B. Data are means ± standard deviations from independent experiments (n = 4). Statistical significance was determined by the Mann-Whitney test for on OD 600 /h and by the Wilcoxon Signed Rank test for incorporated C18:2; ∗, P ≤ 0.05. n.s: not significant. " width="100%" height="100%">

Journal: Journal of Lipid Research

Article Title: Prophages divert Staphylococcus aureus defenses against host lipids

doi: 10.1016/j.jlr.2024.100693

Figure Lengend Snippet: Hlb activity and anti-FASII treatments enhance C18:2 incorporation in S. aureus PLs. TB3 (фNM3 in hlb ) and TB4 (no phage) strains were cultured in BHI medium supplemented with 10% mouse serum, 30 μM 1,3DG, with or without 0.5 μg/ml AFN-1252 (anti-FASII), and with or without 50 μM GW4869 (inhibitor of Hlb). Top left: bacterial growth rates in the absence of anti-FASII treatment, performed in glass tubes. Top right: growth kinetics in the presence of AFN-1252, measured in 96-well microtiter plates with OD600 reading every 10 min. Bottom: C18:2 incorporation with or without AFN-1252. C18:2 incorporation was determined in the TB4 and TB3 strains as described in Figure 2 B. Data are means ± standard deviations from independent experiments (n = 4). Statistical significance was determined by the Mann-Whitney test for on OD 600 /h and by the Wilcoxon Signed Rank test for incorporated C18:2; ∗, P ≤ 0.05. n.s: not significant.

Article Snippet: Stocks of trilinolein (TG18:2, 50 mM), triarachidonin (TG20:4, 10 mM), trieicosapentaenoin (TG20:5, 50 mM), tridocosahexaenoin (TG22:6, 50 mM), 1,2-dilinoleoylglycerol (1,2DG, 50 mM), 1,3-dilinoleoylglycerol (1,3DG, 50 mM), palmitic acid (C16, 100 mM), (Larodan Fine Chemicals), orlistat (38 mM, MedChemExpress), and the anti-FASII antibiotic AFN-1252 (1 mg/ml, MedChemExpress) were prepared in DMSO.

Techniques: Activity Assay, Cell Culture, MANN-WHITNEY